Microdermabrasion + meso system FDA Approved

Ultrapeel? II plus Transderm? Meso? System

Be sure your patients get the results they expect. (FDA Approved & CE Certificate)

The Ultrapeel? II & Transderm? Meso? System is the new non-invasive, stand alone powered, drug-delivery Technology from Mattioli Engineering.  This solution offers medical professionals the ability to deliver Ionic Drug Solutions into the body through the use of  our patented process of Dermoelectroporation?.  This proven method is a welcome alternative to injections and offers patients a pleasant massage sensation during treatments with our patented vibration feature.

Ultrapeel? Transderm? Meso? System uses Dermoelectroporation ? Technology to deliver any active ingredient into the body and when connected to Ultrapeel? microdermabrader
allows a very efficient transdermal delivery of products.

Patients will enjoy treatments with Ultrapeel? II plus Transderm ? Meso? System due to the highly comfortable sessions. The vibration feature makes the electrical pulse delivery
perception to decrease significantly.

Ultrapeel? Transderm? Meso? System Benefits

• Ensures speed of action.
• Easier regulation of either current delivery and vibration.
• Monitors Skin impedance in Real time to give users the final results they expect.
• The light applicators allow users to work greatly for any skin condition and any length of treatment.

Ultrapeel? II plus Transderm? Meso? System is made of the following devices:

1. Ultrapeel? II plus digitally controlled microdermabrader
2. Transderm? Meso? delivery display w/applicator
3. Super Precision Liquid Dispenser *

_{* Super PLD Macromolecules (greater than15.000 Dalton) previously not transdermally deliverable by traditional Ionthophoresis are now successfully deliverable due this outstanding Dermoelectroporation ? Technology.}